FIELD: pharmaceuticals.
SUBSTANCE: invention relates to novel compounds of formula I:
, as well as pharmaceutical compositions based thereon.
EFFECT: obtaining novel compounds that activate procaspase-3, which can induce the death of cancer cells.
8 cl, 2 tbl, 3 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS BASED ON 7-SUBSTITUTED PYRROLOTRIAZINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS FOR THEIR PREPARATION AND APPLICATION | 2018 |
|
RU2745548C1 |
| LIGANDS FOR AGGREGATED MOLECULES OF TAU-PROTEIN | 2009 |
|
RU2518892C2 |
| COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS | 2014 |
|
RU2661878C2 |
| DERIVATIVE BASED ON DIHYDROPYRIMIDO-RING AS HBV INHIBITOR | 2015 |
|
RU2693897C2 |
| COMPOUND, METHOD FOR PREPARATION AND USE THEREOF FOR PRODUCING ANTICANCER DRUG | 2021 |
|
RU2821945C1 |
| PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2589053C1 |
| DISCLOSED ARE 3,6-DIAMINOPYRIDAZIN-3-YL DERIVATIVES CONTAINING PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS PRO-APOPTOTIC AGENTS | 2020 |
|
RU2830186C2 |
| ENANTIOSELECTIVE SYNTHESIS OF DERIVATIVES OF GAMMA-AMINO-ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS | 2009 |
|
RU2512499C2 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| O-AMINOHETEROARYLALKYNYL CONTAINING COMPOUND, METHOD FOR ITS PRODUCTION AND ITS USE | 2018 |
|
RU2797694C2 |
